Evidence map›Paper›PMID 18682113›Full record

ReviewCurrent allergy and asthma reports2008

Innate immune mechanism in allergic asthma.

Carlos J Suarez, Nathan J Parker, Patricia W Finn

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current allergy and asthma reports, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Chronic inflammation and asthma.Mutation research · 2010
    Review
  12. Article
  13. Review
  14. Review
  15. T lymphocyte apoptosis in asthma.European journal of medical research · 2009
    Review
  16. A low dose of Mycoplasma pneumoniae infection enhances an established allergic inflammation in mice: the role of the prostaglandin E2 pathway.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2009
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carlos J SuarezDivision of Pulmonary and Critical Care, University of California, San Diego, 9500 Gilman Drive #0643, La Jolla, CA 92096-0643, USA.
Nathan J Parker
Patricia W Finn

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allergic asthma is a chronic inflammatory disorder of the airways characterized by eosinophilic inflammation, airway hyperresponsiveness, and mucus hypersecretion. Adaptive, antigen-dependent immunity is critical for asthma pathogenesis. Allergic asthma may involve adaptive and innate, antigen-independent immune responses. This review discusses the current evidence that associates innate immunity with allergic asthma pathogenesis. In particular, we focus on the role of innate immune cells (eg, bronchial epithelial cells, alveolar macrophages, and dendritic cells) and molecules (Toll-like and nucleotide-binding oligomerization domain-like receptors) in modifying allergic immune responses.

Indexed as

Immunity, InnateAnimalsAsthmaBacteriaBacterial InfectionsBronchiCytokinesDendritic CellsEpithelial CellsHumansInflammation MediatorsMacrophages, AlveolarNod Signaling Adaptor ProteinsRespiratory MucosaT-Lymphocyte SubsetsToll-Like ReceptorsCytokinesInflammation MediatorsNod Signaling Adaptor ProteinsToll-Like Receptors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.